(Epi)Genomics Core
(Epi)基因组学核心
基本信息
- 批准号:10261989
- 负责人:
- 金额:$ 52.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-19 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAllelesAllergic DiseaseAsthmaBiologicalBiological AssayBiologyCandidate Disease GeneCell LineCellsChromatinComputing MethodologiesConsensusDNA MethylationDataDevelopmentDissectionDistantEnhancersEtiologyGenerationsGenesGeneticGenetic TranscriptionGenomeGenomic SegmentGenomic approachGenomicsGoalsHeritabilityHi-CHumanImmunologicsIn VitroIndividualLengthLinkMapsMeasuresMediatingModelingPathogenesisPhenotypePropertyPublishingRNARegulator GenesRegulatory ElementReporterResearchRestSpecificityStatistical MethodsStimulusTestingTissuesTranscriptional RegulationTranslationsUntranslated RNAVariantWorkbisulfite sequencingcausal variantcell typechromosome conformation capturecombinatorialcomputer frameworkdesigndisorder riskepigenomicsexperimental studygenetic associationgenetic variantgenome wide association studygenome-widegenomic datain vitro testingin vivoin vivo Modelinnovationnew therapeutic targetnovelpromoterresponsetranscription factortranscriptome sequencingwhole genome
项目摘要
SUMMARY
While GWAS have identified hundreds of genetic variants in at least 150 loci associated with asthma and
allergic diseases (AAD), the translation of those findings into a better understanding of asthma etiology have
lagged significantly. This is due, in part, to the fact that most AAD-associated variants are in noncoding
sequences, often at great distance from genes. The underlying consensus is that a number of these variants
impart their effects in disease risk by disrupting the regulatory properties of regulatory elements, such as
enhancers and promoters. The challenges to efficiently extract hypothesis-generating information from GWAS
loci include i) identifying the causal variant(s) in each GWAS locus, ii) determining the type of regulatory
element in which these variants are mapped, iii) inferring the tissue-specificity of these regulatory elements, iv)
defining the target genes for these regulatory elements, and v) demonstrating a phenotypic effect of these
variants. This Center proposal aims to develop a computational and experimental framework to tackle all these
outstanding challenges. In Project 1, an innovative statistical and computational framework will be developed
to link functional annotations in AAD-associated loci to identify candidate variants, regulatory sequences and
genes that are mediating the genetic association. These annotations will be generated from cells obtained in
Project 2, which iteratively will also be able to test some of the predictions made from Project 1 in in vitro and in
vivo models. The generation of the functional annotations necessitate the use of several state-of-the-art
genomics strategies. The goal of the (Epi)Genomics Core (EGC) is to serve as the genomics data generation
hub for this Center. We propose t carry over 500 whole-genome assays in multiple asthma-relevant primary
cell types obtained in Project 2. In Aim 1 we will generate transcription and chromatin accessibility maps for
each of these cells under baseline and stimulated conditions. We will utilize a suite of complementary
chromatin accessibility assays, including ATAC-seq, KAS-sew and whole genome bisulfite sequencing, in
addition to RNA-seq to generate dynamic transcription maps in each cell line in response to specific stimuli. In
Aim 2 we will “wire” regulatory elements to their target genes, utilizing chromatin conformation capture. Finally,
we will test the regulatory potential of thousands of candidate variants identified in Project 1 in a massively
parallel reporter assay. The combination of comprehensive functional annotations in multiple cell types and
states represent an ambitious departure from the traditional efforts to link variants to function in single loci to a
systematic approach that interrogates the whole genome at once. We anticipate that our research strategy will
generate a large number of specific hypothesis that will be pursued in similar ways to what we propose in
Project 2. As such, the EGC will serve as an experimental node connecting the 2 individual projects.
摘要
而GWAS已经在至少150个与哮喘和哮喘相关的基因座上发现了数百个基因变异
过敏性疾病(AAD),将这些发现转化为对哮喘病因的更好理解
明显落后。这在一定程度上是因为大多数与AAD相关的变体都是非编码的
序列,通常距离基因很远。潜在的共识是,这些变体中的一些
通过扰乱监管要素的监管性质来传递它们在疾病风险方面的影响,例如
促进剂和促进剂。如何有效地从GWAS中提取假设生成信息面临的挑战
基因座包括:i)识别每个Gwas基因座中的因果变量(S);ii)确定调控基因的类型
这些变异体被定位的元素,iii)推断这些调控元素的组织特异性,iv)
定义这些调控元件的目标基因,以及v)展示这些元件的表型效应
变种。该中心的提案旨在开发一个计算和实验框架来解决所有这些问题
突出的挑战。在项目1中,将制定一个创新的统计和计算框架
连接AAD相关基因座中的功能注释以确定候选变异体、调控序列和
调节基因关联的基因。这些批注将从中获取的像元生成
项目2,它还将能够反复地在体外和在
活体模型。函数注释的生成需要使用几种最先进的技术
基因组学策略。(Epi)基因组学核心(EGC)的目标是作为基因组学数据的生成
该中心的枢纽。我们建议在多个与哮喘相关的原发病例中进行500多项全基因组分析。
在项目2中获得的细胞类型。在目标1中,我们将生成转录和染色质可及性图
这些细胞中的每一个都处于基线和刺激条件下。我们将利用一套互补的
染色质可及性分析,包括ATAC-SEQ、KAS-SEW和全基因组亚硫酸盐测序
添加到RNA-seq以在每个细胞系中生成响应特定刺激的动态转录图谱。在……里面
目标2我们将利用染色质构象捕捉,将调控元件与其目标基因“连接”。最后,
我们将大规模测试项目1中确定的数千个候选变体的调控潜力
平行报告试验。多种单元格类型中的综合功能批注和
各州代表着与传统努力的雄心勃勃的背道而驰,这些努力将单基因座中起作用的变异与
一次询问整个基因组的系统化方法。我们预计我们的研究战略将
生成大量特定的假设,这些假设将以类似于我们在
因此,EGC将作为连接两个单独项目的实验节点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marcelo A. Nobrega其他文献
Upregulation of emSYNGAP1/em expression in mice and human neurons by redirecting alternative splicing
通过重定向可变剪接来上调小鼠和人类神经元中 emSYNGAP1/em 的表达
- DOI:
10.1016/j.neuron.2023.02.021 - 发表时间:
2023-05-17 - 期刊:
- 影响因子:15.000
- 作者:
Runwei Yang;Xinran Feng;Alejandra Arias-Cavieres;Robin M. Mitchell;Ashleigh Polo;Kaining Hu;Rong Zhong;Cai Qi;Rachel S. Zhang;Nathaniel Westneat;Cristabel A. Portillo;Marcelo A. Nobrega;Christian Hansel;Alfredo J. Garcia III;Xiaochang Zhang - 通讯作者:
Xiaochang Zhang
Enhancers: five essential questions
增强子:五个关键问题
- DOI:
10.1038/nrg3458 - 发表时间:
2013-03-18 - 期刊:
- 影响因子:52.000
- 作者:
Len A. Pennacchio;Wendy Bickmore;Ann Dean;Marcelo A. Nobrega;Gill Bejerano - 通讯作者:
Gill Bejerano
Upregulation of emSYNGAP1/em expression in mice and human neurons by redirecting alternative splicing
通过重定向可变剪接来上调小鼠和人类神经元中 emSYNGAP1/em 的表达
- DOI:
10.1016/j.neuron.2023.02.021 - 发表时间:
2023-05-17 - 期刊:
- 影响因子:15.000
- 作者:
Runwei Yang;Xinran Feng;Alejandra Arias-Cavieres;Robin M. Mitchell;Ashleigh Polo;Kaining Hu;Rong Zhong;Cai Qi;Rachel S. Zhang;Nathaniel Westneat;Cristabel A. Portillo;Marcelo A. Nobrega;Christian Hansel;Alfredo J. Garcia III;Xiaochang Zhang - 通讯作者:
Xiaochang Zhang
Comparative genomics at the vertebrate extremes
脊椎动物极端情况下的比较基因组学
- DOI:
10.1038/nrg1350 - 发表时间:
2004-06-01 - 期刊:
- 影响因子:52.000
- 作者:
Dario Boffelli;Marcelo A. Nobrega;Edward M. Rubin - 通讯作者:
Edward M. Rubin
Marcelo A. Nobrega的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marcelo A. Nobrega', 18)}}的其他基金
Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases
综合遗传、组学和免疫学研究,以确定哮喘和过敏性疾病的内型和新药物靶点
- 批准号:
10453773 - 财政年份:2021
- 资助金额:
$ 52.73万 - 项目类别:
Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases
综合遗传、组学和免疫学研究,以确定哮喘和过敏性疾病的内型和新药物靶点
- 批准号:
10261987 - 财政年份:2021
- 资助金额:
$ 52.73万 - 项目类别:
Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases
综合遗传、组学和免疫学研究,以确定哮喘和过敏性疾病的内型和新药物靶点
- 批准号:
10615778 - 财政年份:2021
- 资助金额:
$ 52.73万 - 项目类别:
Functional Genomics of IL-33 expression and asthma risk
IL-33 表达和哮喘风险的功能基因组学
- 批准号:
9247245 - 财政年份:2014
- 资助金额:
$ 52.73万 - 项目类别:
Functional Genomics of IL-33 expression and asthma risk
IL-33 表达和哮喘风险的功能基因组学
- 批准号:
8721683 - 财政年份:2014
- 资助金额:
$ 52.73万 - 项目类别:
Functional Genomics of IL-33 Expression and Asthma Risk
IL-33 表达和哮喘风险的功能基因组学
- 批准号:
9281175 - 财政年份:2014
- 资助金额:
$ 52.73万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 52.73万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 52.73万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 52.73万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 52.73万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 52.73万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 52.73万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 52.73万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 52.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 52.73万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 52.73万 - 项目类别: